Increased urinary l-histidine in patients with asthma–chronic obstructive pulmonary disease overlap
J. Shim (Seoul, Republic of Korea), J. Oh (Seoul, Republic of Korea), J. Choi (Seoul, Republic of Korea), Y. Lee (Seoul, Republic of Korea), K. Min (Seoul, Republic of Korea), G. Hur (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea), K. Kang (Seoul, Republic of Korea)
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Shim (Seoul, Republic of Korea), J. Oh (Seoul, Republic of Korea), J. Choi (Seoul, Republic of Korea), Y. Lee (Seoul, Republic of Korea), K. Min (Seoul, Republic of Korea), G. Hur (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea), K. Kang (Seoul, Republic of Korea). Increased urinary l-histidine in patients with asthma–chronic obstructive pulmonary disease overlap. 5470
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: